Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #3152 on Jaguar Health Inc (JAGX)
powerbattles
02/23/24 8:56 AM
#3154 RE: TJG #3152
OnTarget Study Results "We continue to work diligently to complete the comprehensive analysis of the data from our pivotal Phase 3 OnTarget trial of our novel plant-based prescription drug crofelemer for the follow-on indication of the preventative treatment of cancer therapy-related diarrhea."
oldstocks
02/23/24 9:18 AM
#3159 RE: TJG #3152